Atrial fibrillation. Atrial fibrillation and flutter
Conditions
Interventions
Intervention 1: Intervention group will receive SMS reminder for INR test and physicians will use CDSS. Intervention 2: Control group will not receive any reminder.
Prevention
Treatment - Drugs
Control group will not receive any reminder
Intervention group will receive SMS reminder for INR test and physicians will use CDSS
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Newly diagnosed AF that must take warfarin with outpatient follow-up will be included. Patients will be excluded from the study when they or their families do not have mobile phones for sending SMS.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percent time in therapeutic INR range. Timepoint: With each patient visit. Method of measurement: Therapeutic INR range for newly diagnosed AF patient is 2.0-3.0.;Carrying out the INR test in a timely manner. Timepoint: With each patient visit. Method of measurement: Compare the date on which the test must be done with a date that has been really done. | — |
Secondary
| Measure | Time frame |
|---|---|
| Thromboembolic events. Timepoint: At least nine months later in the follow-up period. Method of measurement: Number of events.;Bleeding. Timepoint: At least nine months later in the follow-up period. Method of measurement: number of events.;Mortality. Timepoint: At least nine months later in the follow-up period. Method of measurement: number of events. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactReza Sheibani
Mashhad University of Medical Sciences
Outcome results
None listed